Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Q-linea AB (3F80) Stock Price & Analysis

3F80 Stock Chart & Stats

€1.32-€0.02(-1.13%)
At close: 5:30 PM GMT+1
€0€500€1K8 Nov27 Jan17 Nov31 Jan7 Jan24 Mar23 Sep16 Apr22 Oct
Day’s Range
EUR 1.32 - EUR 1.32
52-Week Range
EUR 1.32 - EUR 3.15
Previous Close
EUR 1.33
Volume
0
Average Volume (3M)
0
Market Cap
EUR 25.76M
Enterprise Value
EUR 197.75M
Total Cash (Recent Filing)
EUR 150.71M
Total Debt (Recent Filing)
EUR 16.86M
Price to Earnings (P/E)
―
Beta
82.04
Next Earnings
Feb 12, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

Revenue growth indicates that Q-linea is achieving some commercial traction in infectious-disease diagnostics, despite its small base. If this expansion continues, greater instrument and consumable adoption could improve operating leverage and provide a foundation for future profitability.

Low Leverage

Very low debt relative to equity gives Q-linea a less leveraged financial structure and reduces the immediate burden of interest and refinancing obligations. This provides greater flexibility to direct available resources toward commercial development while limiting balance-sheet sensitivity to operating volatility.

Improved Equity Position

The return to a sizeable positive equity base represents a meaningful structural improvement from the stressed 2024 position. A stronger capital cushion can support business continuity and reduce balance-sheet fragility, although its durability ultimately depends on whether ongoing losses and cash use are brought under control.

Bears Say

Persistent Unprofitability

Deeply negative gross profit shows that Q-linea is not yet covering the direct economics of its business, while operating and net losses indicate additional costs remain unsupported by revenue. This weak profitability limits internally funded growth and makes sustainable earnings dependent on substantial improvement in economics.

Heavy Cash Burn

Materially negative operating and free cash flow means the company continues to consume cash rather than fund operations organically. The deteriorating TTM free-cash-flow trend increases the importance of external funding or a rapid operating improvement, potentially constraining investment and strategic flexibility over the next several quarters.

Erosion Risk From Losses

A deeply negative return on equity signals that the current capital base is not producing shareholder returns and remains exposed to continued depletion through losses. If profitability does not stabilize, repeated cash deficits could reduce the improved equity cushion and recreate balance-sheet pressure over time.

Q-linea AB News

3F80 FAQ

What was Q-linea AB’s price range in the past 12 months?
Q-linea AB lowest stock price was €1.32 and its highest was €3.15 in the past 12 months.
What is Q-linea AB’s market cap?
Q-linea AB’s market cap is €25.76M.
When is Q-linea AB’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Q-linea AB’s earnings last quarter?
Q-linea AB released its earnings results on Oct 30, 2026. The company reported -€0.141 earnings per share for the quarter.
Is Q-linea AB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Q-linea AB pay dividends?
Q-linea AB does not currently pay dividends.
What is Q-linea AB’s EPS estimate?
Q-linea AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Q-linea AB have?
Q-linea AB has 18,949,081 shares outstanding.
What happened to Q-linea AB’s price movement after its last earnings report?
Q-linea AB reported an EPS of -€0.141 in its last earnings report. Following the earnings report the stock price went down -1.128%.
Which hedge fund is a major shareholder of Q-linea AB?
Currently, no hedge funds are holding shares in DE:3F80
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology